Skip to content
Recall Observatory FDA recall evidence

Drug product

Zonisamide Capsules USP, 25 mg, packaged in 100-count bottles, Rx Only, Manufactured by: Glenmark Pharmaceuticals, Inc., USA Monroe, NC 28110, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, NDC 68462-128-01

D-0791-2022

April 25, 2022

Class II

Product summary

Firm
Glenmark Pharmaceuticals Inc., USA
Event
Event 90029
Status
Completed
Classification
Class II
Quantity
11,136 bottles
Official record key
drug-enforcement:D-0791-2022

Official wording

Reason: cGMP deviations

Code information: Lot #: 29200052, Exp 4/30/2023

Distribution pattern: USA nationwide

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    cGMP deviations